Global Atherosclerosis Therapeutics Market (2025-2031) | Restraints, Size, Revenue, Analysis, Outlook, Growth, Drivers, Segmentation, Share, Strategy, Consumer Insights, Value, Forecast, Supply, Pricing Analysis, Competition, Industry, Challenges, Strategic Insights, Opportunities, Investment Trends, Companies, Segments, Competitive, Trends, Demand

Global Atherosclerosis Therapeutics Market Size & Growth Rate

Global Atherosclerosis Therapeutics Market Overview

The Global Atherosclerosis Therapeutics Market is experiencing steady growth due to the increasing prevalence of cardiovascular diseases worldwide. Atherosclerosis is a major contributor to heart attacks and strokes, driving the demand for effective therapeutic interventions. The market is characterized by a wide range of drugs and treatment options, including statins, antiplatelet agents, ACE inhibitors, and surgery. The growing adoption of novel therapies such as PCSK9 inhibitors and advanced imaging techniques for early diagnosis and monitoring is expected to further propel market growth. Key players in the market are investing in research and development to introduce innovative treatments and improve patient outcomes. However, factors such as high treatment costs and stringent regulatory requirements may hinder market expansion in certain regions.

Global Atherosclerosis Therapeutics Market Trends and Opportunities

The Global Atherosclerosis Therapeutics Market is witnessing a growing demand for innovative treatments and personalized medicine approaches. Advancements in technology and research have led to the development of novel therapies targeting specific pathways involved in atherosclerosis progression. Additionally, the increasing prevalence of lifestyle-related risk factors such as obesity and diabetes is driving the market growth. Opportunities in the market include the exploration of combination therapies, gene editing techniques, and precision medicine strategies to improve treatment outcomes and reduce cardiovascular events. Furthermore, the rising adoption of minimally invasive procedures and the development of targeted drug delivery systems offer promise for more effective and efficient atherosclerosis management. Overall, the market is poised for significant growth and evolution in the coming years.

Global Atherosclerosis Therapeutics Market Challenges

The Global Atherosclerosis Therapeutics Market faces several challenges, including the complex nature of the disease itself, as atherosclerosis involves the buildup of plaque in arteries over time and can lead to various cardiovascular complications. Another challenge is the presence of multiple risk factors such as high cholesterol, high blood pressure, and smoking, which can complicate treatment strategies. Additionally, there is a need for more effective and targeted therapies to address the diverse patient populations affected by atherosclerosis. Regulatory hurdles, high development costs, and competition from other therapeutic options also pose challenges in the market. Overall, navigating these obstacles requires innovative research, strategic partnerships, and a deep understanding of the evolving landscape of atherosclerosis treatment.

Global Atherosclerosis Therapeutics Market Drivers

The Global Atherosclerosis Therapeutics Market is primarily driven by the increasing prevalence of cardiovascular diseases, including atherosclerosis, worldwide. Factors such as unhealthy diet habits, sedentary lifestyles, smoking, and rising geriatric population contribute to the growing burden of atherosclerosis. Additionally, advancements in medical technology and the development of innovative therapeutics targeting atherosclerosis are fueling market growth. Moreover, the rising awareness about the importance of early diagnosis and treatment of atherosclerosis among both healthcare providers and patients is driving the demand for effective therapeutics. Government initiatives aimed at reducing the burden of cardiovascular diseases and improving access to healthcare services are also significant drivers shaping the Global Atherosclerosis Therapeutics Market.

Global Atherosclerosis Therapeutics Market Government Policy

Government policies related to the Global Atherosclerosis Therapeutics Market focus on promoting drug safety, efficacy, and accessibility. Regulatory bodies such as the FDA in the United States and the EMA in Europe oversee the approval and monitoring of atherosclerosis drugs to ensure they meet stringent quality and safety standards. These agencies also encourage research and development initiatives through grants and partnerships to advance treatment options for atherosclerosis. In addition, government healthcare programs and policies aim to improve patient access to atherosclerosis medications through insurance coverage and affordability initiatives. Overall, government policies in the Global Atherosclerosis Therapeutics Market are geared towards ensuring the availability of safe and effective treatments for patients while promoting innovation and accessibility in the industry.

Global Atherosclerosis Therapeutics Market Future Outlook

The Global Atherosclerosis Therapeutics Market is expected to witness steady growth in the coming years due to the rising prevalence of cardiovascular diseases worldwide. With an increasing aging population and unhealthy lifestyle choices contributing to the development of atherosclerosis, there is a growing demand for effective treatment options. Technological advancements in drug development, along with a focus on personalized medicine and targeted therapies, are likely to drive innovation and market expansion. Additionally, the introduction of novel therapies such as PCSK9 inhibitors and anti-inflammatory drugs holds promise for improving patient outcomes. However, challenges such as generic competition, stringent regulatory requirements, and high treatment costs may hinder market growth to some extent. Overall, the market is anticipated to experience moderate growth with a shift towards more advanced and personalized treatment approaches.

Global Atherosclerosis Therapeutics Market Regional Insights

The Global Atherosclerosis Therapeutics Market is expected to witness significant growth across all regions, with Asia Pacific leading the market expansion due to the rising prevalence of atherosclerosis risk factors such as obesity and unhealthy diet. North America is anticipated to hold a substantial market share owing to the presence of key market players, advanced healthcare infrastructure, and high healthcare expenditure. In Europe, the market growth is driven by increasing awareness about atherosclerosis management and the launch of novel therapeutics. The Middle East and Africa region are projected to experience steady growth due to improving healthcare facilities and rising healthcare investments. Latin America is also expected to contribute to market growth due to the increasing adoption of advanced treatment options and a growing geriatric population prone to atherosclerosis.

Key Highlights of the Report:

• Global Atherosclerosis Therapeutics Market Outlook
• Market Size of Global Atherosclerosis Therapeutics Market, 2024
• Forecast of Global Atherosclerosis Therapeutics Market, 2031
• Historical Data and Forecast of Global Atherosclerosis Therapeutics Revenues & Volume for the Period 2021 - 2031
• Global Atherosclerosis Therapeutics Market Trend Evolution
• Global Atherosclerosis Therapeutics Market Drivers and Challenges
• Global Atherosclerosis Therapeutics Price Trends
• Global Atherosclerosis Therapeutics Porter's Five Forces
• Global Atherosclerosis Therapeutics Industry Life Cycle
• Historical Data and Forecast of Global Atherosclerosis Therapeutics Market Revenues & Volume
• Historical Data and Forecast of Global Atherosclerosis Therapeutics Market Revenues & Volume By Drug Treatment for the Period 2021 - 2031
• Historical Data and Forecast of Global Atherosclerosis Therapeutics Market Revenues & Volume By Anti-Platelet Medications for the Period 2021 - 2031
• Historical Data and Forecast of Global Atherosclerosis Therapeutics Market Revenues & Volume By Cholesterol Lowering Medications for the Period 2021 - 2031
• Historical Data and Forecast of Global Atherosclerosis Therapeutics Market Revenues & Volume By Beta Blockers for the Period 2021 - 2031
• Historical Data and Forecast of Global Atherosclerosis Therapeutics Market Revenues & Volume By Angiotensin-Converting Enzyme (ACE) Inhibitors for the Period 2021 - 2031
• Historical Data and Forecast of Global Atherosclerosis Therapeutics Market Revenues & Volume By Calcium Channel Blockers for the Period 2021 - 2031
• Historical Data and Forecast of Global Atherosclerosis Therapeutics Market Revenues & Volume By Water Pills for the Period 2021 - 2031
• Historical Data and Forecast of Global Atherosclerosis Therapeutics Market Revenues & Volume By Others for the Period 2021 - 2031
• Historical Data and Forecast of Global Atherosclerosis Therapeutics Market Revenues & Volume By Distribution Channel for the Period 2021 - 2031
• Historical Data and Forecast of Global Atherosclerosis Therapeutics Market Revenues & Volume By Direct Tender for the Period 2021 - 2031
• Historical Data and Forecast of Global Atherosclerosis Therapeutics Market Revenues & Volume By Hospital Pharmacy for the Period 2021 - 2031
• Historical Data and Forecast of Global Atherosclerosis Therapeutics Market Revenues & Volume By Retail Pharmacy for the Period 2021 - 2031
• Historical Data and Forecast of Global Atherosclerosis Therapeutics Market Revenues & Volume By Online Pharmacy for the Period 2021 - 2031
• Historical Data and Forecast of Global Atherosclerosis Therapeutics Market Revenues & Volume By Others for the Period 2021 - 2031
• Historical Data and Forecast of North America Atherosclerosis Therapeutics Market Revenues & Volume By Drug Treatment for the Period 2021 - 2031
• Historical Data and Forecast of North America Atherosclerosis Therapeutics Market Revenues & Volume By Anti-Platelet Medications for the Period 2021 - 2031
• Historical Data and Forecast of North America Atherosclerosis Therapeutics Market Revenues & Volume By Cholesterol Lowering Medications for the Period 2021 - 2031
• Historical Data and Forecast of North America Atherosclerosis Therapeutics Market Revenues & Volume By Beta Blockers for the Period 2021 - 2031
• Historical Data and Forecast of North America Atherosclerosis Therapeutics Market Revenues & Volume By Angiotensin-Converting Enzyme (ACE) Inhibitors for the Period 2021 - 2031
• Historical Data and Forecast of North America Atherosclerosis Therapeutics Market Revenues & Volume By Calcium Channel Blockers for the Period 2021 - 2031
• Historical Data and Forecast of North America Atherosclerosis Therapeutics Market Revenues & Volume By Water Pills for the Period 2021 - 2031
• Historical Data and Forecast of North America Atherosclerosis Therapeutics Market Revenues & Volume By Others for the Period 2021 - 2031
• Historical Data and Forecast of North America Atherosclerosis Therapeutics Market Revenues & Volume By Distribution Channel for the Period 2021 - 2031
• Historical Data and Forecast of North America Atherosclerosis Therapeutics Market Revenues & Volume By Direct Tender for the Period 2021 - 2031
• Historical Data and Forecast of North America Atherosclerosis Therapeutics Market Revenues & Volume By Hospital Pharmacy for the Period 2021 - 2031
• Historical Data and Forecast of North America Atherosclerosis Therapeutics Market Revenues & Volume By Retail Pharmacy for the Period 2021 - 2031
• Historical Data and Forecast of North America Atherosclerosis Therapeutics Market Revenues & Volume By Online Pharmacy for the Period 2021 - 2031
• Historical Data and Forecast of North America Atherosclerosis Therapeutics Market Revenues & Volume By Others for the Period 2021 - 2031
• Historical Data and Forecast of United States of America Atherosclerosis Therapeutics Market Revenues & Volume for the Period 2021 - 2031
• Historical Data and Forecast of Canada Atherosclerosis Therapeutics Market Revenues & Volume for the Period 2021 - 2031
• Historical Data and Forecast of Rest of North America Atherosclerosis Therapeutics Market Revenues & Volume for the Period 2021 - 2031
• Historical Data and Forecast of Latin America (LATAM) Atherosclerosis Therapeutics Market Revenues & Volume By Drug Treatment for the Period 2021 - 2031
• Historical Data and Forecast of Latin America (LATAM) Atherosclerosis Therapeutics Market Revenues & Volume By Anti-Platelet Medications for the Period 2021 - 2031
• Historical Data and Forecast of Latin America (LATAM) Atherosclerosis Therapeutics Market Revenues & Volume By Cholesterol Lowering Medications for the Period 2021 - 2031
• Historical Data and Forecast of Latin America (LATAM) Atherosclerosis Therapeutics Market Revenues & Volume By Beta Blockers for the Period 2021 - 2031
• Historical Data and Forecast of Latin America (LATAM) Atherosclerosis Therapeutics Market Revenues & Volume By Angiotensin-Converting Enzyme (ACE) Inhibitors for the Period 2021 - 2031
• Historical Data and Forecast of Latin America (LATAM) Atherosclerosis Therapeutics Market Revenues & Volume By Calcium Channel Blockers for the Period 2021 - 2031
• Historical Data and Forecast of Latin America (LATAM) Atherosclerosis Therapeutics Market Revenues & Volume By Water Pills for the Period 2021 - 2031
• Historical Data and Forecast of Latin America (LATAM) Atherosclerosis Therapeutics Market Revenues & Volume By Others for the Period 2021 - 2031
• Historical Data and Forecast of Latin America (LATAM) Atherosclerosis Therapeutics Market Revenues & Volume By Distribution Channel for the Period 2021 - 2031
• Historical Data and Forecast of Latin America (LATAM) Atherosclerosis Therapeutics Market Revenues & Volume By Direct Tender for the Period 2021 - 2031
• Historical Data and Forecast of Latin America (LATAM) Atherosclerosis Therapeutics Market Revenues & Volume By Hospital Pharmacy for the Period 2021 - 2031
• Historical Data and Forecast of Latin America (LATAM) Atherosclerosis Therapeutics Market Revenues & Volume By Retail Pharmacy for the Period 2021 - 2031
• Historical Data and Forecast of Latin America (LATAM) Atherosclerosis Therapeutics Market Revenues & Volume By Online Pharmacy for the Period 2021 - 2031
• Historical Data and Forecast of Latin America (LATAM) Atherosclerosis Therapeutics Market Revenues & Volume By Others for the Period 2021 - 2031
• Historical Data and Forecast of Brazil Atherosclerosis Therapeutics Market Revenues & Volume for the Period 2021 - 2031
• Historical Data and Forecast of Mexico Atherosclerosis Therapeutics Market Revenues & Volume for the Period 2021 - 2031
• Historical Data and Forecast of Argentina Atherosclerosis Therapeutics Market Revenues & Volume for the Period 2021 - 2031
• Historical Data and Forecast of Rest of LATAM Atherosclerosis Therapeutics Market Revenues & Volume for the Period 2021 - 2031
• Historical Data and Forecast of Asia Atherosclerosis Therapeutics Market Revenues & Volume By Drug Treatment for the Period 2021 - 2031
• Historical Data and Forecast of Asia Atherosclerosis Therapeutics Market Revenues & Volume By Anti-Platelet Medications for the Period 2021 - 2031
• Historical Data and Forecast of Asia Atherosclerosis Therapeutics Market Revenues & Volume By Cholesterol Lowering Medications for the Period 2021 - 2031
• Historical Data and Forecast of Asia Atherosclerosis Therapeutics Market Revenues & Volume By Beta Blockers for the Period 2021 - 2031
• Historical Data and Forecast of Asia Atherosclerosis Therapeutics Market Revenues & Volume By Angiotensin-Converting Enzyme (ACE) Inhibitors for the Period 2021 - 2031
• Historical Data and Forecast of Asia Atherosclerosis Therapeutics Market Revenues & Volume By Calcium Channel Blockers for the Period 2021 - 2031
• Historical Data and Forecast of Asia Atherosclerosis Therapeutics Market Revenues & Volume By Water Pills for the Period 2021 - 2031
• Historical Data and Forecast of Asia Atherosclerosis Therapeutics Market Revenues & Volume By Others for the Period 2021 - 2031
• Historical Data and Forecast of Asia Atherosclerosis Therapeutics Market Revenues & Volume By Distribution Channel for the Period 2021 - 2031
• Historical Data and Forecast of Asia Atherosclerosis Therapeutics Market Revenues & Volume By Direct Tender for the Period 2021 - 2031
• Historical Data and Forecast of Asia Atherosclerosis Therapeutics Market Revenues & Volume By Hospital Pharmacy for the Period 2021 - 2031
• Historical Data and Forecast of Asia Atherosclerosis Therapeutics Market Revenues & Volume By Retail Pharmacy for the Period 2021 - 2031
• Historical Data and Forecast of Asia Atherosclerosis Therapeutics Market Revenues & Volume By Online Pharmacy for the Period 2021 - 2031
• Historical Data and Forecast of Asia Atherosclerosis Therapeutics Market Revenues & Volume By Others for the Period 2021 - 2031
• Historical Data and Forecast of China Atherosclerosis Therapeutics Market Revenues & Volume for the Period 2021 - 2031
• Historical Data and Forecast of India Atherosclerosis Therapeutics Market Revenues & Volume for the Period 2021 - 2031
• Historical Data and Forecast of Japan Atherosclerosis Therapeutics Market Revenues & Volume for the Period 2021 - 2031
• Historical Data and Forecast of Rest of Asia Atherosclerosis Therapeutics Market Revenues & Volume for the Period 2021 - 2031
• Historical Data and Forecast of Africa Atherosclerosis Therapeutics Market Revenues & Volume By Drug Treatment for the Period 2021 - 2031
• Historical Data and Forecast of Africa Atherosclerosis Therapeutics Market Revenues & Volume By Anti-Platelet Medications for the Period 2021 - 2031
• Historical Data and Forecast of Africa Atherosclerosis Therapeutics Market Revenues & Volume By Cholesterol Lowering Medications for the Period 2021 - 2031
• Historical Data and Forecast of Africa Atherosclerosis Therapeutics Market Revenues & Volume By Beta Blockers for the Period 2021 - 2031
• Historical Data and Forecast of Africa Atherosclerosis Therapeutics Market Revenues & Volume By Angiotensin-Converting Enzyme (ACE) Inhibitors for the Period 2021 - 2031
• Historical Data and Forecast of Africa Atherosclerosis Therapeutics Market Revenues & Volume By Calcium Channel Blockers for the Period 2021 - 2031
• Historical Data and Forecast of Africa Atherosclerosis Therapeutics Market Revenues & Volume By Water Pills for the Period 2021 - 2031
• Historical Data and Forecast of Africa Atherosclerosis Therapeutics Market Revenues & Volume By Others for the Period 2021 - 2031
• Historical Data and Forecast of Africa Atherosclerosis Therapeutics Market Revenues & Volume By Distribution Channel for the Period 2021 - 2031
• Historical Data and Forecast of Africa Atherosclerosis Therapeutics Market Revenues & Volume By Direct Tender for the Period 2021 - 2031
• Historical Data and Forecast of Africa Atherosclerosis Therapeutics Market Revenues & Volume By Hospital Pharmacy for the Period 2021 - 2031
• Historical Data and Forecast of Africa Atherosclerosis Therapeutics Market Revenues & Volume By Retail Pharmacy for the Period 2021 - 2031
• Historical Data and Forecast of Africa Atherosclerosis Therapeutics Market Revenues & Volume By Online Pharmacy for the Period 2021 - 2031
• Historical Data and Forecast of Africa Atherosclerosis Therapeutics Market Revenues & Volume By Others for the Period 2021 - 2031
• Historical Data and Forecast of South Africa Atherosclerosis Therapeutics Market Revenues & Volume for the Period 2021 - 2031
• Historical Data and Forecast of Nigeria Atherosclerosis Therapeutics Market Revenues & Volume for the Period 2021 - 2031
• Historical Data and Forecast of Egypt Atherosclerosis Therapeutics Market Revenues & Volume for the Period 2021 - 2031
• Historical Data and Forecast of Rest of Africa Atherosclerosis Therapeutics Market Revenues & Volume for the Period 2021 - 2031
• Historical Data and Forecast of Europe Atherosclerosis Therapeutics Market Revenues & Volume By Drug Treatment for the Period 2021 - 2031
• Historical Data and Forecast of Europe Atherosclerosis Therapeutics Market Revenues & Volume By Anti-Platelet Medications for the Period 2021 - 2031
• Historical Data and Forecast of Europe Atherosclerosis Therapeutics Market Revenues & Volume By Cholesterol Lowering Medications for the Period 2021 - 2031
• Historical Data and Forecast of Europe Atherosclerosis Therapeutics Market Revenues & Volume By Beta Blockers for the Period 2021 - 2031
• Historical Data and Forecast of Europe Atherosclerosis Therapeutics Market Revenues & Volume By Angiotensin-Converting Enzyme (ACE) Inhibitors for the Period 2021 - 2031
• Historical Data and Forecast of Europe Atherosclerosis Therapeutics Market Revenues & Volume By Calcium Channel Blockers for the Period 2021 - 2031
• Historical Data and Forecast of Europe Atherosclerosis Therapeutics Market Revenues & Volume By Water Pills for the Period 2021 - 2031
• Historical Data and Forecast of Europe Atherosclerosis Therapeutics Market Revenues & Volume By Others for the Period 2021 - 2031
• Historical Data and Forecast of Europe Atherosclerosis Therapeutics Market Revenues & Volume By Distribution Channel for the Period 2021 - 2031
• Historical Data and Forecast of Europe Atherosclerosis Therapeutics Market Revenues & Volume By Direct Tender for the Period 2021 - 2031
• Historical Data and Forecast of Europe Atherosclerosis Therapeutics Market Revenues & Volume By Hospital Pharmacy for the Period 2021 - 2031
• Historical Data and Forecast of Europe Atherosclerosis Therapeutics Market Revenues & Volume By Retail Pharmacy for the Period 2021 - 2031
• Historical Data and Forecast of Europe Atherosclerosis Therapeutics Market Revenues & Volume By Online Pharmacy for the Period 2021 - 2031
• Historical Data and Forecast of Europe Atherosclerosis Therapeutics Market Revenues & Volume By Others for the Period 2021 - 2031
• Historical Data and Forecast of United Kingdom Atherosclerosis Therapeutics Market Revenues & Volume for the Period 2021 - 2031
• Historical Data and Forecast of France Atherosclerosis Therapeutics Market Revenues & Volume for the Period 2021 - 2031
• Historical Data and Forecast of Germany Atherosclerosis Therapeutics Market Revenues & Volume for the Period 2021 - 2031
• Historical Data and Forecast of Rest of Europe Atherosclerosis Therapeutics Market Revenues & Volume for the Period 2021 - 2031
• Historical Data and Forecast of Middle East Atherosclerosis Therapeutics Market Revenues & Volume By Drug Treatment for the Period 2021 - 2031
• Historical Data and Forecast of Middle East Atherosclerosis Therapeutics Market Revenues & Volume By Anti-Platelet Medications for the Period 2021 - 2031
• Historical Data and Forecast of Middle East Atherosclerosis Therapeutics Market Revenues & Volume By Cholesterol Lowering Medications for the Period 2021 - 2031
• Historical Data and Forecast of Middle East Atherosclerosis Therapeutics Market Revenues & Volume By Beta Blockers for the Period 2021 - 2031
• Historical Data and Forecast of Middle East Atherosclerosis Therapeutics Market Revenues & Volume By Angiotensin-Converting Enzyme (ACE) Inhibitors for the Period 2021 - 2031
• Historical Data and Forecast of Middle East Atherosclerosis Therapeutics Market Revenues & Volume By Calcium Channel Blockers for the Period 2021 - 2031
• Historical Data and Forecast of Middle East Atherosclerosis Therapeutics Market Revenues & Volume By Water Pills for the Period 2021 - 2031
• Historical Data and Forecast of Middle East Atherosclerosis Therapeutics Market Revenues & Volume By Others for the Period 2021 - 2031
• Historical Data and Forecast of Middle East Atherosclerosis Therapeutics Market Revenues & Volume By Distribution Channel for the Period 2021 - 2031
• Historical Data and Forecast of Middle East Atherosclerosis Therapeutics Market Revenues & Volume By Direct Tender for the Period 2021 - 2031
• Historical Data and Forecast of Middle East Atherosclerosis Therapeutics Market Revenues & Volume By Hospital Pharmacy for the Period 2021 - 2031
• Historical Data and Forecast of Middle East Atherosclerosis Therapeutics Market Revenues & Volume By Retail Pharmacy for the Period 2021 - 2031
• Historical Data and Forecast of Middle East Atherosclerosis Therapeutics Market Revenues & Volume By Online Pharmacy for the Period 2021 - 2031
• Historical Data and Forecast of Middle East Atherosclerosis Therapeutics Market Revenues & Volume By Others for the Period 2021 - 2031
• Historical Data and Forecast of Saudi Arabia Atherosclerosis Therapeutics Market Revenues & Volume for the Period 2021 - 2031
• Historical Data and Forecast of UAE Atherosclerosis Therapeutics Market Revenues & Volume for the Period 2021 - 2031
• Historical Data and Forecast of Turkey Atherosclerosis Therapeutics Market Revenues & Volume for the Period 2021 - 2031
• Historical Data and Forecast of Rest of Middle East Atherosclerosis Therapeutics Market Revenues & Volume for the Period 2021 - 2031
• Global Atherosclerosis Therapeutics Market - Key Performance Indicators
• Global Atherosclerosis Therapeutics Market - Import Export Trade Statistics
• Global Atherosclerosis Therapeutics Market - Opportunity Assessment By Countries
• Global Atherosclerosis Therapeutics Market - Opportunity Assessment By Drug Treatment
• Global Atherosclerosis Therapeutics Market - Opportunity Assessment By Distribution Channel
• Global Atherosclerosis Therapeutics Market - Top Companies Market Share
• Global Atherosclerosis Therapeutics Market - Top Companies Profiles
• Global Atherosclerosis Therapeutics Market - Comparison of Players in Technical and Operating Parameters
• Global Atherosclerosis Therapeutics Market - Strategic Recommendations